STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00088088 · COMPLETED
Trial details
- NCT number
- NCT00088088
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.